GHT Gold Health Tech
search
Available for inquiry

Medium Reagent

Reference: 1052178 Laboratory Medicine
ApplicationsFor Qpcr, For Cancers
TypeReagent Medium
Other CharacteristicsAssayed
FormatLiquid

Associated tags

Back to catalog
verified_user

Product review

inventory_2

Catalog record

support_agent

Inquiry support

description

Product summary

The PlentiPlex™ MYD88 qPCR Assay is engineered to operate on conventional real-time PCR equipment and offers a combination of high sensitivity and user-friendliness. The PlentiPlex™ MYD88 L265P assay is constructed using PentaBase's innovative and selective INA® technologies, which include the utilization of BaseBlockers™ to suppress false positive PCR signals from wild type templates.input:
output:Procedure for opening the qPCR instrument

0.6-0.75% MYD88 L265P LOD

Based on INA® technology, results are achieved in less than two hours.CE IVD with minimal hands-on timeinput:
output:Product Description: PCR master mix and oligonucleotide mix for the quantification of the MYD88 L265P mutation, a positive control.input:
output:Format: Dispense Ready, Ready for Useinput:
output:Reactions: twelve to twenty-oneinput:
output:Waldenström PlentiPlex™ MYD88 The Lymphoma qPCR Assay is a semi-quantitative real-time Polymerase Chain Reaction (PCR) assay that is designed for the in vitro diagnosis of the genomic DNA (gDNA) change that induces a leucine to proline mutation in codon 265 (L265P) of the Myeloid differentiation primary response 88 (MYD88).Samples will be collected from blood or Formalin-Fixed Paraffin-Embedded (FFPE) tissue. The assay is employed in conjunction with real-time PCR systems, and samples can be prepared using automated platforms or manual workflows. The PlentiPlex™ MYD88 Waldenström Lymphoma qPCR Assay results are intended to facilitate the differentiation between Lymphoplasmacytic lymphoma/Waldenström macroglobulinemia (LPL/WM) and non-Hodgkin lymphoma by identifying the presence of the MYD88 L265P.

Related products